XML 32 R8.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net loss $ (48,079) $ (20,563) $ (8,517)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation expense 120 90 12
Stock-based compensation expense 6,104 891 27
Write-down of property and equipment held for sale 216 289  
Non-cash charges related to Vixen acquisition 2,784    
Changes in operating assets and liabilities:      
Prepaid expenses and other assets (8) (1,269) (152)
Accounts payable 1,810 (359) 819
Accrued expenses 2,450 552 175
Net cash used in operating activities (34,603) (20,369) (7,636)
Cash flows from investing activities:      
Purchases of property and equipment (232) (507) (417)
Purchases of marketable securities (148,764) (82,513) (5,035)
Proceeds from sales and maturities of marketable securities 87,093 6,069 3,673
Net cash used in investing activities (61,903) (76,951) (1,779)
Cash flows from financing activities:      
Proceeds from issuance of common stock in connection with private placement, net of issuance costs 18,547    
Proceeds from follow-on public offering, net of issuance costs 98,158    
Proceeds from initial public offering, net of offering costs   56,550  
Proceeds from issuance of convertible preferred stock, net of issuance costs   39,864 10,584
Proceeds from the exercise of employee stock options 121    
Net cash provided by financing activities 116,826 96,414 10,584
Net increase (decrease) in cash and cash equivalents 20,320 (906) 1,169
Cash and cash equivalents at beginning of period 9,851 10,757 9,588
Cash and cash equivalents at end of period 30,171 9,851 10,757
Supplemental disclosures of non-cash investing and financing activities:      
Additions to property and equipment included in accounts payable 11 2 91
Fair value of stock issued in connection with Vixen acquisition 2,355    
Offering costs included in accounts payable $ 250    
Accretion of convertible preferred stock to redemption value   $ 1,764 2,054
Fair value of preferred stock purchased put option on date of issuance     $ 1,039